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Background: Preterm birth associates with a substantially increased risk of later 
cardiovascular disease and neurodevelopmental disorders. Understanding underlying 
mechanisms will facilitate the development of screening and intervention strategies to 
reduce disease risk. Changes in DNA methylation have been proposed as one mecha-
nism linking the early environment with later disease risk. We tested the hypothesis that 
preterm birth associates with altered DNA methylation in genes encoding insulin-like 
growth factor 2 (IGF2) and FK506-binding protein 5 (FKBP5), which appear particularly 
vulnerable to early life adversity.
Methods: Fifty preterm infants were seen and assessed at birth, term equivalent age, 
3 months and 1-year corrected ages; 40 term infants were seen at birth, 3 months and 
1 year. Saliva was collected for DNA extraction at birth, term, and 1 year. Pyrosequencing 
of bisulfite-converted DNA was performed to measure DNA methylation at specific CpG 
sites within the IGF2 and FKBP5 loci.
results: Weight and head circumference was reduced in preterm infants at all time 
points. Preterm infants had a higher percentage body fat at term-corrected age, but 
this difference was not persistent. DNA methylation at the differentially methylated 
region (DMR) of IGF2 (IGF2DMR2) and FKBP5 was lower in preterm infants at birth- and 
term-corrected age compared to term infants at birth. IGF2DMR2 and FKBP5 methyl-
ation was related to birthweight SD score in preterm infants. Among preterm infants, 
social deprivation was an independent contributor toward reducing DNA methylation 
at IGF2DMR2 at birth- and term-corrected age and maternal smoking was associated 
with reduced DNA methylation at FKBP5 at birth. There were no persistent differences in 
DNA methylation at 1 year of age.
conclusion: Changes in DNA methylation were identified at key regions of IGF2/H19 
and FKBP5 in preterm infants in early life. Potential contributing factors include maternal 
smoking and social deprivation. However, these changes did not persist at 1 year of 
age and further longitudinal studies are required to determine any associations between 
altered DNA methylation in the perinatal period of individuals born preterm and their 
long-term health.
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inTrODUcTiOn
Epidemiological evidence linking low birthweight with an 
increased risk of cardiovascular disease as well as developmental 
neuropsychiatric disorders (1) has led to the concept of “early life 
programming.” This proposes that exposure to adverse conditions 
during critical stages of early development results in a change in 
the offspring structural and functional phenotype (2). Preterm 
birth acts as a profound challenge in early life. There is now 
substantial evidence that prematurity associates with risk factors 
for cardiovascular disease in adulthood, including hypertension 
and insulin resistance (3–5). Furthermore, preterm birth is 
closely associated with neurodevelopmental disorders including 
cognitive impairment and autism spectrum disorder (6). This 
has important implications for public health, since worldwide, 
15 million infants are born preterm every year, and survival rates 
have increased markedly over recent years (7).
Factors acting during intrauterine development, which may be 
important in mediating programing effects in infants born small 
at term, include undernutrition and glucocorticoid overexposure. 
These may be of particular importance in infants born preterm. 
In addition, preterm infants are vulnerable to these factors acting 
in early postnatal life (4). Following birth, many preterm infants 
develop a cumulative protein and energy deficit and exhibit early 
postnatal growth failure (8). Preterm infants are additionally 
exposed to repeated stressful and often painful procedures dur-
ing a period of rapid brain maturation, and several studies have 
shown an impact of these procedures on neurodevelopment and 
hypothalamic–pituitary–adrenal (HPA) axis activity (9, 10).
Understanding the mechanisms by which prematurity associ-
ates with long-term effects on health would facilitate the develop-
ment of effective screening and intervention strategies. Changes 
in DNA methylation have been proposed as one mechanism link-
ing early life events and later disease risk (11), and genome-wide 
profiling has revealed DNA methylation differences between 
preterm and term infants in early life (12–14). Exposure to an 
adverse environment in early life has repeatedly been associated 
with altered DNA methylation at a gene of particular importance 
for fetal growth: the imprinted gene insulin-like growth fac-
tor 2 (IGF2). IGF2 is a key growth factor, particularly in early 
development. IGF2 expression is controlled by DNA methylation 
at a number of differentially methylated regions (DMRs) (15) 
and altered IGF2 DNA methylation has been reported following 
exposure to altered maternal nutrition including severe famine 
(16, 17).
The early life environment can also impact on the normal 
functioning of the HPA axis, with implications for neurodevelop-
ment. Exposure to an adverse environment pre- or postnatally 
has been associated with altered DNA methylation at a number 
of genes important in determining HPA axis function, including 
the glucocorticoid receptor (GR) and 11beta-hydroxysteroid 
dehydrogenase type 2 (11β-HSD2). Differences in DNA meth-
ylation at GR and 11β-HSD2 in placenta have been reported in 
association with infant behavioral development (18); however, 
we have previously reported that DNA methylation at GR and 
11β-HSD2 is extremely low in individuals exposed to an adverse 
early life environment and is, therefore, unlikely to impact on 
gene expression (17). FK506-binding protein 5 (FKBP5) encodes 
a co-chaperone of GR and is induced following stress exposure 
through GR binding to specific genomic response elements; 
in turn, FKBP5 protein binds to the GR complex, reducing its 
affinity for cortisol and decreasing nuclear translocation (19). 
Thus, it is an important component of the stress response. A 
functional polymorphism in FKBP5 intron 2 alters mRNA and 
protein induction following GR activation (20), such that the 
allele associated with stronger FKBP5 mRNA induction associ-
ates with GR resistance and an increased risk of a number of 
psychiatric disorders following childhood trauma (20). Exposure 
to childhood trauma leads to allele-specific epigenetic changes, 
with a GR-binding-induced decrease in DNA methylation within 
a functional glucocorticoid response element in intron 7, specifi-
cally, in carriers of the risk allele (20). Further, DNA methylation 
of FKBP5 in placenta associates with infant arousal scores (21).
In this study, we tested the hypothesis that preterm birth, 
a profound stressor in early life, associates with altered DNA 
methylation at the candidate loci IGF2 and FKBP5, which may 
be particularly vulnerable to early life adversity, and examined 
whether any changes were persistent over the first year of life.
MaTerials anD MeThODs
cohort
Fifty preterm (<32 weeks gestation) and 40 term (37–42 weeks 
gestation) infants were recruited within the first week of life 
from the Simpson Center for Reproductive Health, Edinburgh, 
UK, with informed written parental consent. Ethical approval 
was obtained from the South East Scotland Research Ethics 
Committee (Reference 11/AL/0329). NHS management 
approval was obtained (Lothian R&D Project number 2011/R/
NE/03). Perinatal samples were collected under the Edinburgh 
Reproductive Tissue BioBank (ERTBB) (West of Scotland 
Research Ethics Service Reference 09/S0704/3). All parents 
gave written informed consent and all studies were performed 
in accordance with the declaration of Helsinki. Infant samples 
were collected under the framework of the ERTBB follow-
ing an amendment to ethical approval (Reference AM07/1). 
Demographic details were obtained during clinic visits and 
from hospital records. All of the preterm infants were admit-
ted to the neonatal unit; of these, six infants died. In three of 
these infants, saliva for buccal cells was not collected after birth 
due to clinical instability and DNA was of poor quality in a 
fourth infant. Five of the term infants were also admitted to the 
neonatal unit for a short period (respiratory distress syndrome, 
weight loss, and hemolysis from Rhesus isoimmunization) but 
none required follow-up. Preterm infants were seen at birth, 
at term-corrected age, and at 3  months and 1-year corrected 
ages; term infants were seen at birth, 3 months, and 1 year. All 
visits occurred in the afternoon, supervised by one researcher 
(Chinthika Piyasena).
growth and Body composition
Weight, length, and occipitofrontal head circumference (OFC) 
was measured by one trained researcher. Percentage body fat mass 
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was measured by air displacement plethysmography in preterm 
infants at term-corrected age and 3 months corrected age, and 
in term infants at birth and 3 months using the PEAPOD Body 
Composition System (COSMED, Chicago, IL, USA). Skin fold 
thickness (subscapular and triceps) was measured at 1 year by the 
same trained researcher. Term infants were measured at a median 
of 2 days (range 0–8) after birth, at 3 months (13.3 weeks; range 
10.4–16.9), and 1  year (52.3  weeks; range 48.1–57.4). Preterm 
infants were measured at term-corrected age at a median of 40 
(range 35 + 0 to 44 + 1)-corrected weeks, at 3 months corrected 
(13.4 weeks; range 10.3–18.3) and 1 year corrected (53.9 weeks; 
range 52.1–68.7).
analysis of Dna Methylation
Saliva was collected using the Oragene DNA (OG-250) kits 
and saliva sponges CS-1 and extracted using prepIT-2LP (DNA 
Genotek, Ottawa, ON, Canada). DNA was quantified using the 
Qubit 2.0 Fluorometer (Life Technologies, Paisley, UK). Five 
hundred nanograms of DNA were bisulfite converted using the 
EZ DNA Methylation Gold Kit (Zymo Research Corporation, 
CA, USA). Pyrosequencing was performed to analyze DNA 
methylation for DMRs controlling IGF2 expression: IGF2 DMR2 
(IGF2DMR2, n = 9 CpGs) and the H19 imprinting control region 
(H19ICR, n =  8 CpGs) as previously described (22). Primers 
were purchased from Invitrogen (Life Technologies, Paisley, 
UK). DNA was amplified using the AmpliTaq Gold 360 kit 
(Applied Biosystems, Warrington, UK) and pyrosequencing per-
formed using PyroMark Q24Gold reagents on a PyroMark Q24 
Pyrosequencer (Qiagen, Crawley, UK). Data were analyzed using 
PyroMark Q24 1.0.10. Percentage DNA methylation is expressed 
as the average across all CpGs in each of the two loci in IGF2.
Methylation analysis of three CpGs in FKBP5 intron 7, two 
of which are located in consensus GRE motif (CpG 2 and 3), 
was performed in triplicates using a protocol adapted from 
Klengel et  al. (20). One hundred twenty nanograms genomic 
DNA was bisulfite converted using the EZ DNA Methylation 
Kit (Zymo Research Corporation, CA, USA). Bisulfite converted 
DNA was amplified in a 50 µl reaction mix (4–10 µl DNA; each 
bisulfite specific Primer with a final concentration of 0.2  µM, 
FKBP5int7_P1_F: GTTGTTTTTGGAATTTAAGGTAATTG, 
and FKBP5int7_P1_R_biot: biotin-TCTCTTACCTCCAACAC-
TACTACTAAAA) using the Kapa HIFI Uracil  +  Hot start 
Ready Mix (Kapa Biosystems Inc., Wilmington, DE, USA). 
Cycling conditions of the touchdown PCR were 98°C for 
5 min, 2× (98°C – 40 s, 62°C – 30 s, 72°C – 60 s), 5× (98°C – 
40  s, 60°C – 30  s, 72°C – 60  s), 8× (98°C – 40  s, 58°C – 30  s, 
72°C – 60 s), 34× (98°C – 40 s, 56°C – 30 s, 72°C – 60 s), 72°C 
for 1 min and cooling to 4°C. Pyrosequencing of FKBP5 CpGs 
was performed on a PyroMark Q96 ID system (QIAGEN 
GmbH, Hilden) using PyroMark Q96Gold reagents with the 
following sequencing primer: FKBP5int7_P1_S2: 5′-GTT 
GATATATAGGAATAAAATAAGA-3′ for CpG1 and CpG2 and 
FKBP5int7_P1_S3: 5′-TGGAGTTATAGTGTAGGTTTT-3′ for 
CpG3. PyroMark Q96 ID Software 2.5 (QIAGEN GmbH, Hilden) 
was used to calculate percentage methylation.
The legends for Figures 1 and 2 state the number of values/
measurements analyzed, excluding samples, which were discarded 
because of insufficient DNA and/or poor pyrosequencing qual-
ity. Additionally, we were unable to collect saliva from several 
babies for various reasons, although these babies still underwent 
anthropometry.
FKBP5 snP genotyping
FKBP5 rs1360780 genotyping was performed on a Roche 
LightCycler 480 System using a TaqMan SNP Genotyping Assay 
(Applied Biosystems). Thermal cycling conditions were 95°C for 
10 min, 45× (95°C – 15 s, 60°C – 1 min, 50°C – 30 s). Genotypes 
were called using endpoint genotyping LightCycler 480 Software 
version 1.5. Genotypes were in Hardy–Weinberg equilibrium 
(p =  0.17). Participants were divided into protective–genotype 
(CC) and risk-allele carriers (CT or TT).
covariates
Covariates that could confound the association or be in the 
causal pathway were added into the model in a hierarchical 
manner: maternal smoking, male gender, and social depriva-
tion for FKBP5 and IGF2/H19. Additionally, breast milk at 
3  months for IGF2/H19 at 1  year and risk-allele carriage for 
FKBP5 at all time points. Social deprivation was coded as 
deprivation category (DEPCAT) scores based on the mother’s 
postcode at booking and obtained from the “Carstairs scores 
for Scottish postcode sectors from the 2001 Census.” In this 
system, scoring is based on the material affluence/deprivation 
of the area in which a person lives. Postcode sectors are allo-
cated a DEPCAT score, derived from four sets of information: 
overcrowding, male unemployment, car ownership, and the 
proportion of people in households in social class 4 or 5 and 
scores range from 1 to 7 where 7 indicates the worst social 
deprivation. Maternal smoking was categorized as current 
smoker, never smoked, former (stopped pre-pregnancy), or 
former (stopped during pregnancy). Breast milk at 3 months 
indicates whether or not the infant was receiving any breast 
milk at 3 months corrected age.
statistics
Weight, length, OFC, skin fold thickness, and weight gain were 
adjusted for age and gender by converting to SD scores (SDS) 
(z-scores) using LMSgrowth, a Microsoft Excel Add-in to access 
growth references that define the UK-WHO growth charts (23). 
Demographic, clinical characteristics, and risk-allele carriage 
between preterm and term infants were compared using inde-
pendent samples t-testing and chi-square analyses, as appropri-
ate. Multivariate linear regression was used to assess variation in 
body composition and to test the hypothesis that preterm birth 
is associated with altered DNA methylation. Outcome variables 
were percentage DNA methylation at birth, term-corrected age, 
and 1  year. Unstandardized regression (β) coefficients from 
these models indicate the change in percentage methylation 
associated with prematurity and a one-unit change in the other 
predictors. Paired samples t-testing was used where appropriate. 
One-way ANOVA with Dunnett’s post  hoc t testing was used 
to test the effect of maternal smoking on DNA methylation at 
FKBP5. Statistical significance for all analyses was set at p < 0.05 
(two-tailed).
FigUre 1 | growth of term and preterm infants over the first year: box and whisker plots: Tukey with line at median (+ indicates mean). (a) Weight, 
OFC, and length at birth- and term-corrected age. Term infants: n = 40, preterm infants: n = 43. (B) Weight, OFC, and length at 3 months/3 months-corrected age. 
Term infants n = 35, preterm infants n = 35. (c) Weight, OFC, and length at 1 year/1-year corrected. Term infants n = 35, preterm infants n = 42. (D) % fat mass in 
preterm and term infants at birth- and term-corrected age and 3 months of age. Term infants: n = 32 at birth and 30 at 3 months, preterm infants: n = 21 at 
term-corrected age and 32 at 3 months corrected. (e) Skinfold thickness in term and preterm infants at 1 year/1-year corrected. Term infants n = 32, preterm 
infants, n = 31 (n denotes the number of measurements obtained). *p < 0.05, **p < 0.001.
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resUlTs
Preterm and Term infant Demographics
Characteristics of the cohort are shown in Table 1. Birth weight 
SDS was lower in preterm infants p < 0.001, and there were more 
males in the preterm group, p = 0.006. There was no significant 
difference between the frequency of FKBP5 risk-allele carriage 
between the groups (p = 0.43). Maternal age, body mass index 
(BMI), DEPCAT scores, folic acid in first trimester, and maternal 
smoking were different between the two groups.
growth and Body composition
Weight and OFC was reduced in preterm infants at all time points 
compared to term infants (Figures 1A–C). Preterm infants were 
shorter than term infants at term-corrected age and 3 months cor-
rected age, but not at 1-year corrected (Figures 1A–C). Preterm 
infants had a higher percentage body fat at term-corrected age 
when compared with term infants at birth (Figure  1D) (mean 
difference 5.5%, 95% CI [8.0, 3.0], p < 0.001) and this remained 
significant following adjustment for gender (β = 5.7, 95% CI [3.1, 
8.3], p <  0.001). The difference in percentage body fat did not 
persist at 3 months/3 months corrected, including when adjusted 
for gender and breast milk intake (β = −0.3, 95% CI [−2.8, 2.2], 
p = 0.82) (Figure 1D). At 1-year corrected, preterm infants had 
lower triceps skin fold thickness SDS than term infants, adjusted 
for breast milk exposure at 3 months (β = −0.4, 95% CI [−1.3, 
−0.3], p = 0.008), but there were no differences in subscapular 
skin fold thickness (Figure 1E).
Prematurity and Dna Methylation
Mean DNA methylation at IGF2DMR2 was lower in preterm 
infants at birth compared to term infants at birth and this 
remained significant in adjusted analyses (β = −11.2, 95% CI 
[−15.2, −7.3], p < 0.001) (Figure 2B). There was no difference 
in mean DNA methylation at the H19ICR between preterm and 
term infants at birth after adjusted analysis (β = −1.3, 95% CI 
[−3.8, 1.2], p =  0.3) (Figure  2A). In preterm infants at term-
corrected age, DNA methylation was reduced at IGF2DMR2 and 
H19ICR compared to infants born at term, and this remained 
significant in adjusted analyses (β  =  −2.8, 95% CI [−5.0, 
−0.6], p = 0.01 and β = −2.3, 95% CI [−4.6, −0.1], p = 0.049, 
respectively) (Figures  2A,B). However, the significance was 
attenuated when social deprivation was added into the model 
for IGF2DMR2 (β = −2.1, 95% CI [−4.3, 0.05], p = 0.055). At 
1 year of age, there was no difference in mean DNA methyla-
tion in adjusted analyses at either IGF2DMR2 (β = −0.3, 95% 
FigUre 2 | Percentage Dna methylation at IGF2/H19 and FKBP5: box and whisker plots: Tukey with line at median (+indicates mean). (a) % DNA 
methylation at H19ICR: term infants: n = 28 at birth and 31 at 1 year. Preterm infants: n = 23 at birth, 31 at term corrected, and 32 at 1-year corrected. (B) % DNA 
methylation at IGF2DMR2: term infants: n = 25 at birth and 23 at 1 year. Preterm infants: n = 22 at birth, 32 at term corrected, and 28 at 1-year corrected. (c) DNA 
methylation at FKBP5 CpG1: term infants: n = 32 at birth and 31 at 1 year. Preterm infants: n = 27 at birth, 37 at term-corrected age, and 32 at 1-year corrected. 
(D) DNA methylation at FKBP5 CpG2: term infants: n = 28 at birth and 30 at 1 year. Preterm infants: n = 25 at birth, 33 at term-corrected age, and 32 at 1-year 
corrected. (e) DNA methylation at FKBP5 CpG3: term infants: n = 30 at birth and 30 at 1 year. Preterm infants: n = 27 at birth, 36 at term-corrected age, and 36 at 
1-year corrected (n denotes the number of measurements obtained). *p < 0.05, **p < 0.001.
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CI [−4.0, 3.3], p = 0.86) or H19ICR (β = 0.8, 95% CI [−1.5, 3.0], 
p = 0.49) (Figures 2A,B).
The presence of the FKBP5 risk allele was associated with 
higher DNA methylation at FKBP5 CpG3 at birth (β = 4.0, 95% 
CI [0.3, 7.6], p = 0.03) and term-corrected age (β = 2.5, 95% CI 
[0.4, 4.5], p = 0.02) across all infants. DNA methylation at CpG1, 
CpG2, and CpG3 was lower in preterm infants at birth and at 
term-corrected age when compared to term infants at birth, 
including after adjusted analysis (Table 2). There was an increase 
in DNA methylation at all three CpGs in both groups during the 
first year (Figures  2C–E) and, by 1  year of age, there were no 
persistent differences in mean methylation at any CpG between 
preterm and term infants (Table  2). The presence/absence of 
the FKBP5 risk allele as a covariate did not alter the findings at 
1 year and there was no moderation of the relationship between 
prematurity and DNA methylation by the presence of the risk 
allele at any time.
Body composition and Dna Methylation
IGF2DMR2 methylation was highly significantly related to birth-
weight SDS in preterm (R = 0.7, p < 0.001), but not term infants. 
DNA methylation across FKBP5 was also positively associated 
with birthweight SDS (β = 0.3, 95% CI [0.3, 5.4], p = 0.03) when 
adjusted for prematurity, but only in the preterm infants when 
analyzed separately (R = 0.4, p = 0.04). There were no other sig-
nificant relationships between DNA methylation at IGF2DMR2, 
TaBle 1 | characteristics of the study participants.
Term Preterm p-Value
infant characteristics
Gestation at birth, weeks 40.2 ± 1.1 28.5 ± 2.1 <0.001
Birth weight, g 3,649 ± 517 1,136 ± 350 <0.001
Birth weight SDS 0.44 ± 1.0 −0.44 ± 0.9 <0.001
Male, n (%) 15 (38) 35 (70) 0.006
Death, n (%) 0 6 (12)
Bronchopulmonary dysplasia, n (%) 0 14 (31)
Laser for retinopathy of prematurity, n (%) 0 5 (11)
Necrotizing enterocolitis, n (%) 0 6 (13.3)
Intraventricular hemorrhage, n (%) 0 3 (6)
Periventricular leucomalacia, n (%) 0 2 (4.2)
Late onset sepsis, n (%) 0 17 (37)
TPN duration, days 0 17.8 ± 21.8
Any breast milk at 3 months, n (%) 28 (75.7) 9 (22.5) <0.001
FKBP5 risk allele carriage, n (%) 21 (52.5) 28 (60.9) 0.43
Maternal characteristics
Age, years 35.2 ± 4.6 31.3 ± 6.2 0.001
Body mass index at booking, kg/m2 24.3 ± 3.1 27.2 ± 6.9 0.016
High DEPCAT score, n (%) 11 (27.5) 27 (61.4) 0.002
Caucasian ethnicity, n (%) 40 (100) 41 (93.8) 0.09
Smoking, n (%)
Current 0 10 (22.7)
Former – stopped during pregnancy 2 (5) 4 (9.1) 0.5
Former – stopped pre-pregnancy 12 (30) 11 (25) 0.61
Never 26 (65) 18 (40.9) 0.03
Primiparity, n (%) 21 (52.5) 29 (65.9) 0.69
Folic acid during first trimester, n (%) 40 (100) 38 (86.3) <0.001
Assisted reproduction, n (%) 0 6 (13.6)
Multiple pregnancy, n (%) 0 9 (20.4)
Hypertension or preeclampsia, n (%) 0 10 (22.7)
Diabetes during pregnancy, n (%) 0 3 (6.8)
Antenatal steroids, n (%)
None 40 (100) 3 (6.8) <0.001
Incomplete course – 11 (25)
Complete course – 30 (68.2)
Antenatal magnesium sulfate, n (%) 0 10 (22.7)
Cesarean section, n (%) 28 (70) 23 (52.2) 0.1
Labor, n (%) 18 (37.5) 27 (61.4) 0.13
Age of partner 35.3 ± 5.2 33.1 ± 6.9 0.1
Plus–minus values are means ± SD. n = 40 full term and 50 preterm infants. n = 44 
for mothers of preterm infants. Bronchopulmonary dysplasia (BPD) is defined as need 
for respiratory support and/or supplemental oxygen at 36 weeks’ postmenstrual age 
to maintain oxygen saturations of 90% or more. A diagnosis of necrotizing enterocolitis 
was applied when cases achieved Bell stage 2 or greater. Intraventricular hemorrhage 
is defined as only grades III or IV events. The definition of late onset sepsis is taken 
from the Vermont Oxford Network Manual of Operations, release 16.3. Five preterm 
infants died before 36 weeks’ postmenstrual age (mean 24.9 weeks’ gestational age at 
birth, mean 692 g birthweight). A further preterm infant died at term-corrected age from 
severe BPD (26-weeks’ gestation at birth weighing 1,000 g). In three of these infants, 
saliva for buccal cells was not collected after birth due to clinical instability and DNA 
was of poor quality in a fourth infant. Three term infants and six preterm infants were 
not seen at 3 months. High DEPCAT was regarded as scores 4–7.
SDS, SD score; DEPCAT, deprivation category.
6
Piyasena et al. DNA Methylation in Preterm Infants
Frontiers in Endocrinology | www.frontiersin.org December 2016 | Volume 7 | Article 158
H19ICR, or FKBP5 and weight or measures of body composition 
in either preterm or term infants at any other time point (Table 3).
social Deprivation, Maternal smoking, and 
Dna Methylation
Social deprivation was an independent contributor toward reduc-
ing DNA methylation at IGF2DMR2 in preterm infants at birth 
(β = −1.6, 95% CI [−2.8, −0.3], p = 0.02) and at term-corrected 
age (β = −0.9, 95% CI [−1.5, −0.2], p = 0.02) although this did 
not persist at 1-year corrected age (p = 0.07). Social deprivation 
was also independently associated with a reduction in DNA 
methylation at FKBP5 CpG2 in preterm infants at term-corrected 
age (β = −1.5, 95% CI [−2.9, −0.02], p = 0.047). Finally, maternal 
smoking was independently associated with a marked reduc-
tion in DNA methylation in preterm infants at FKBP5 CpG1 
(β = −2.6, 95% CI [−4.4, −0.7], p = 0.008) and CpG2 (β = −2.1, 
95% CI [−4.1, −0.03], p =  0.047) at birth, compared to term 
infants. Additionally, maternal smoking was associated with a 
reduction in DNA methylation at birth in both groups at these 
loci (Table 4).
DiscUssiOn
Preterm infants demonstrated a growth trajectory comparable to 
that reported in previous studies, such that they were lighter than 
term infants during the first year of life (24, 25). Although pre-
term infants had increased percentage fat mass at term-corrected 
age, there was no persisting difference at 3  months. Previous 
studies have reported increased and/or altered fat distribution 
in preterm infants at term-corrected age (26–28), with some 
reporting that these differences had resolved by 3 months (28). 
Despite this apparent resolution of excess adiposity in early life, 
preterm infants do show abnormalities of body composition in 
young adulthood, with higher adiposity, ectopic lipid deposition, 
and increased intra-abdominal fat (29).
DNA methylation at IGF2DMR2 and FKBP5 intron 7 was 
markedly lower in preterm infants at birth in comparison to 
term-born infants, and this was still the case at term-corrected 
age. Although we did not test the functional consequences of 
these alterations in DNA methylation, reduced IGF2DMR2 DNA 
methylation would be predicted to reduce IGF2 expression with 
potential implications for early growth. Reduced methylation 
of FKBP5 intron 7 CpGs is associated with higher induction 
of FKBP5 by GR activation, leading to increased GR resistance 
(20); however, whether this might play a role in the HPA axis 
dysregulation seen in preterm infants (9) is unclear. Social dep-
rivation was an independent predictor of reduced methylation at 
IGF2DMR2 at birth and term-corrected age. Inter-related factors 
such as smoking that accompany socioeconomic deprivation can 
impact on DNA methylation in adults (30), including at FKBP5 
(31). Recent studies in children and adults exposed to cigarette 
smoke in utero have reported alterations in global and site-specific 
DNA methylation (32–35), and our results showing that maternal 
smoking was independently associated with a marked reduction 
in DNA methylation at FKBP5 at birth suggest that this extends 
to effects on FKBP5.
There were no persistent differences in DNA methylation 
at 1 year of age at the DMRs of IGF2 and at FKBP5. Our data 
support an epigenome-wide association study (EWAS), which 
demonstrated that although there were many differences in 
DNA methylation between preterm and term babies at birth, 
these had largely resolved by 18  years of age. However, DNA 
methylation differences did persist at a subset of CpGs (12). This 
TaBle 4 | Dna methylation at FKBP5 according to maternal smoking status.
smoking status cpg1 cpg2 cpg3
Mean seM p-Value Mean seM p-Value Mean seM p-Value
Birth (term and preterm infants)
Never 73.6 1.1 59.9 1.2 20.2 1.0
Former stopped pre-pregnancy 66.1 2.4 0.007 56.4 2.7 0.49 21.4 2.3 0.91
Former stopped during pregnancy 68.8 3.0 0.47 57.0 5.3 0.90 20.8 3.4 1.00
Current 57.1 4.7 0.001 42.5 3.9 0.002 16.9 2.3 0.71
Term age (preterm infants)
Never 62.9 1.4 53.1 1.6 20.4 1.0
Former stopped pre-pregnancy 65.9 1.7 0.51 54.1 1.6 0.96 20.6 1.7 1.00
Former stopped during pregnancy 62.2 5.4 1.00 55.1 1.4 0.95 19.2 1.9 0.97
Current 61.6 2.0 0.95 50.6 2.1 0.71 18.1 1.0 0.66
1 year (term and preterm infants)
Never 80.6 0.5 72.6 0.8 37.8 0.8
Former stopped pre-pregnancy 81.4 1.1 0.82 72.1 0.9 0.97 37.2 1.5 0.97
Former stopped during pregnancy 83.6 1.4 0.23 72.5 1.6 1.00 36.4 2.6 0.91
Current 80.5 1.9 1.00 72.5 1.6 1.00 40.0 3.1 0.79
Smoking status is recorded as never (regarded as the control group for one-way ANOVA and Dunnett’s post hoc t testing), former smokers who stopped before pregnancy, former 
smokers who stopped during pregnancy, and current (smokers who continued throughout pregnancy).
TaBle 3 | correlations between percentage Dna methylation at IGF2DMR2, H19ICR, and FKBP5 with weight sDs and percentage body fat.
IGF2DMR H19ICR FKBP5 cpg1 FKBP5 cpg2 FKBP5 cpg3 intron average
R p R p R p R p R p R p
% Dna methylation vs. weight sDs
Term infants at birth vs. birthweight SDS 0 0.98 −0.2 0.44 0 0.83 0.2 0.43 −0.2 0.22 0.2 0.37
Preterm infants at birth vs. birthweight SDS 0.7 <0.001 0.2 0.41 0.6 <0.001 0.5 0.01 0.4 0.04 0.4 0.04
Preterm infants at term age vs. weight SDS 0 0.96 0.2 0.37 0.2 0.34 −0.3 0.16 −0.1 0.53 0.1 0.73
Term infants at 1 year vs. weight SDS −0.1 0.72 0.2 0.28 0 0.89 0.4 0.05 0.4 0.06 0.1 0.79
Preterm infants at 1 year corrected vs. weight SDS −0.06 0.75 0.27 0.14 −0.2 0.29 −0.1 0.51 −0.2 0.22 0 0.86
% Dna methylation vs. % body fat
Term infants at birth vs. % fat 0 0.94 −0.2 0.29 0 0.9 0 0.98 −0.2 0.4 0.2 0.27
Preterm infants at term age vs. % fat −0.2 0.51 −0.2 0.62 0.3 0.17 0.2 0.47 0.2 0.48 −0.1 0.81
TaBle 2 | Dna methylation at FKBP5 in preterm and term infants.
a cpg1 cpg2 cpg3
β p β p β p
Preterm infants at birth vs. term infants at birth  −12.1 [−15.6, −8.8] <0.001 −12.9 [−16.9, −9.0] <0.001 −5.2 [−9.3, −1.2] 0.01
Preterm infants at term-corrected age vs. term infants at birth −11.7 [−14.6, −8.7] <0.001 −7 [−11.5, −2.5] 0.003 −3 [−5.3, −0.7] 0.01
Preterm infants at 1-year corrected vs. term infants at 1 year −1.9 [−4.0, 0.2] 0.07 −2 [−4.4, 0.4] 0.1 3.1 [0.8, 6.0] 0.05
β values represent unstandardized regression coefficients adjusting for male gender, maternal smoking, social deprivation score, and risk-allele carriage. Values in square brackets 
represent 95% confidence intervals.
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EWAS did not identify changes at IGF2 or FKBP5, which may 
reflect that it was small (n = 12 per group) and studied DNA 
methylation changes in blood spots, rather than buccal DNA. 
Our findings are also in agreement with longitudinal EWASs, 
which show that DNA methylation undergoes developmental 
changes during childhood (36). Notably, for FKBP5, DNA 
methylation increased between birth and 1  year in both term 
and preterm infants, and DNA methylation at CpG3 was still 
significantly lower at 1  year of age in comparison to levels 
described in adulthood (20), suggesting that there are ongoing 
changes in DNA methylation at this locus through childhood. 
Since studies clearly show that DNA methylation changes 
through infancy and childhood, it may be that the lower levels of 
DNA methylation in preterm infants at birth is a normal finding 
for infants at this gestation. For obvious reasons, we are unable 
to compare DNA methylation in saliva in infants of comparable 
gestation, who remained in utero. There were some persistent 
differences between term infants and preterm infants at term-
corrected age, and we suggest that this may reflect differences 
between the intrauterine maturation in term-born infants and 
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factors acting during the extra-uterine period to which preterm 
infants are exposed.
Alternative/additional explanations for the differences in 
DNA methylation between preterm and term infants in very 
early life could include the altered nutritional state of infants 
born preterm (37, 38); and/or glucocorticoid overexposure, 
since preterm infants experience both in utero exposure to syn-
thetic glucocorticoids and significant early postnatal “stress.” 
In vivo and in  vitro studies have shown that glucocorticoid 
exposure leads to stable DNA demethylation at these specific 
sites within the FKBP5 locus (20, 39), and several studies have 
now shown that exposure to trauma during childhood associ-
ates with allele-specific demethylation at FKBP5 in adulthood 
(20, 40). Although childhood abuse impacts on DNA methyla-
tion in carriers of the risk allele (20), we found no additional 
effects of the presence or absence of the risk allele. This is 
in agreement with a lack of effect of the risk allele on DNA 
methylation patterns following severe parental trauma (40), 
supporting the concept that these effects are specific to the 
timing of exposure (20), and it may be that the stresses around 
preterm birth occur outside this “vulnerable” period. Finally, 
it is also possible that differences in cell subtype populations in 
the saliva from preterm and term infants may impact on DNA 
methylation (41).
In summary, we found changes in DNA methylation at key 
regions of IGF2/H19 and FKBP5 in this cohort of preterm 
infants who did not achieve the reference for either growth 
or body composition by the time they reached 1 year of age. 
Further, we identified a number of contributing factors includ-
ing maternal smoking and social deprivation. We found no per-
sisting differences at 1 year of age. Whether further differences 
will emerge over longer follow-up is unknown; alterations in 
DNA methylation at key DMRs controlling the expression of 
IGF2 have been reported in adults exposed to altered nutrition 
or prematurity (16, 17, 42); however, these were not longitudi-
nal studies, so that any differences may have arisen postnatally. 
Additionally, these studies may have been complicated by the 
phenomenon of reverse causation, where the development 
of disease leads to changes in DNA methylation rather than 
vice  versa (41). Further longitudinal studies are required to 
understand any potential long-term effects of early differences 
in DNA methylation in the perinatal period on the health of 
individuals born preterm.
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